Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|December 13, 2004
Support grows for VAWD accreditation of wholesalers
The pharmaceutical industry has given a thumbs-up to NABP's voluntary plan to accredit wholesale drug distributors. Nevertheless, representatives from various drug companies gave NABP officials an earful at a seminar for pharmaceutical manufacturers in early November.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Oveporexton Met Primary, Key Secondary End Points in Phase 3 Studies
3
Expert Discusses Flu and COVID-19 Vaccine Guidance
4
Study Finds No Neurodevelopmental Risk in Prenatal COVID-19, Except Speech
5